Trials / Sponsors / Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis Autoimmune Diseases of the Nervous System, Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Phase 2 | 2012-08-01 |
| Terminated | Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome | Phase 2 | 2007-11-01 |
| Completed | Autologous T Cell Vaccine (TCV) for Multiple Sclerosis Relapsing-Remitting Multiple Sclerosis | Phase 2 | 2006-05-01 |
| Completed | Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive | Phase 1 / Phase 2 | 2002-07-01 |